In recognition of a severe unmet need, the Steven & Alexandra Cohen Foundation’s grant to Columbia University established
the first national Columbia Clinical Trials Network Coordinating Center (CTNCC) for Lyme and Other Tick-borne Diseases. Under
the leadership of Dr. Brian Fallon, this Clinical Trials Coordinating Center aims to propel national research toward the goal
of identifying more effective treatments for patients with Lyme and other tick-borne diseases.
Providing oversight to ensure that the highest-quality clinical trials are undertaken, the CTN Coordinating Center at Columbia
will provide funding support for small pilot studies, assist investigators in protocol design and statistical research planning,
establish and manage a national case registry, and create a data management system for multi-site clinical trials. The clinical
trials network will be a powerful engine to drive large-scale clinical trials and potentially transformational early-stage research.
The Clinical Trials Network established with a grant from the Steven & Alexandra Cohen Foundation to Columbia University announces
that the website is now accepting Pilot Study Concept submissions (July 1 to Aug 1).
The Clinical Trials Network welcomes research clinicians and investigators from academic institutions and foundations
to submit proposals. The CTN Study Review Committee will review submissions for consideration for further development
into a pilot study; each pilot study will be conducted at one of the CTN investigation sites. The CTN has funding to support 1-2
small pilot studies each year. Current CTN network affiliates include investigators from Columbia University Irving Medical
Center in New York City, Johns Hopkins University Medical Center in Baltimore Maryland, and Children's National Hospital in Washington D.C.
The CTN Study Review Committee includes the core CTN members, clinical research experts, and academic and community clinicians.
Results of the CTN pilot studies – if favorable – will lead to consideration for larger Randomized Controlled Trials.
The deadline for the first round of submissions for treatment research ideas from the research scientists and clinicians is August 1, 2021.
The submission period opens July 1.
We thank all clinicians and investigators in advance for participation in this process, as your proposal may lead to a transformative study